Tag Archives: FDA

Risky Business of Sleep Drugs

Posted on March 5, 2016 by cchrstl

Risky Business of Sleep Drugs After reading about the dangers of sleeping pills in the February 2016 edition of Consumer Reports magazine, we thought you might like to know something about that. Some psychotropic drugs are prescribed as sleeping pills. Trazodone, … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , , , | Comments Off on Risky Business of Sleep Drugs

Another Day Another Anti-depressant (Again)

Posted on February 25, 2016 by cchrstl

Another Day Another Anti-depressant (Again) On July 10, 2015, the U.S. Food and Drug Administration approved Rexulti (brexpiprazole, an atypical antipsychotic) tablets to treat adults with so-called schizophrenia and as an add-on treatment to an antidepressant medication to treat adults with … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , | Comments Off on Another Day Another Anti-depressant (Again)

Another Day Another Anti-depressant

Posted on January 28, 2016 by cchrstl

Another Day Another Anti-depressant The New Year brings us another harmful psychoactive antidepressant – Brintellix (vortioxetine hydrobromide). The mechanism of the antidepressant effect of vortioxetine is not understood, although it is theorized to be related to serotonin in the brain. It … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , | Comments Off on Another Day Another Anti-depressant

S.2388 Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015

Posted on January 16, 2016 by cchrstl

This bill, S.2388, introduced in the U.S. Senate by Senators Ted Cruz (R-TX) and Mike Lee (R-UT) on 12/10/2015, has been referred to the Committee on Health, Education, Labor, and Pensions (HELP). Its stated purpose is “To amend the Federal Food, Drug, … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , | Comments Off on S.2388 Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2015

MedWatch Consumer Protection

Posted on September 8, 2015 by cchrstl

MedWatch Consumer Protection Landmark Legislation: Consumer Protection MedWatch Phone Number Placed on Generic Prescription Drug Containers in Connecticut For immediate release: Contact Sheila Matthews, Cofounder AbleChild (203) 253-0329 Westport, Connecticut AbleChild is pleased to announce the passage of Connecticut SB … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , | Comments Off on MedWatch Consumer Protection

The New “Female Viagra” is an Antidepressant

Posted on August 29, 2015 by cchrstl

The Food and Drug Administration (FDA) has just approved (18 August, 2015) the drug Addyi (generic flibanserin) which is misleadingly being touted as the “Female Viagra.” But unlike Viagra, which affects blood flow to the male genitals, Addyi, the “pink … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , | 1 Comment

Human Rights Concerns with the Helping Families in Mental Health Crisis Act of 2015

Posted on July 18, 2015 by cchrstl

Human Rights Concerns with the Helping Families in Mental Health Crisis Act of 2015 Congressional Rep. Tim Murphy (R., PA) originally introduced the Helping Families in Mental Health Crisis Act (H.R.3717) in 2013. Not to be outdone by H.R.6 the 21st Century Cures … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , , , , , , | Comments Off on Human Rights Concerns with the Helping Families in Mental Health Crisis Act of 2015

21st Century Cures Act

Posted on July 12, 2015 by cchrstl

21st Century Cures Act H.R.6, the 21st Century Cures Act, is rushing through Congress now. This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) budget, and to make some major changes in the … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , | Comments Off on 21st Century Cures Act

Mallinckrodt Sues FDA Over Methylphenidate

Posted on November 28, 2014 by cchrstl

Mallinckrodt Sues FDA Over Methylphenidate Mallinckrodt is a pharmaceutical company with U.S. headquarters in St. Louis, Missouri. One of their products is the generic drug Methylphenidate HCl Extended-Release (ER); methylphenidate is known as Ritalin or Concerta in some branded versions, … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , | Comments Off on Mallinckrodt Sues FDA Over Methylphenidate

Contrave

Posted on September 21, 2014 by cchrstl

Contrave The U.S. Food and Drug Administration (FDA) approved a new weight loss drug on September 10. Aren’t you excited? Don’t get your hopes up, we’re going to tell you all the reasons you should not take this drug. I … Continue reading →

Posted in Big Muddy River Newsletter, Press Releases | Tagged , , , , , , | Comments Off on Contrave